Sweden: Impilo becomes major shareholder in Pelago Bioscience

In a busy summer for Impilo, a Nordic investment company focused on long-term investments in sustainable healthcare companies active in pharmaceuticals, medical technology, healthcare services, and other health-related areas, the firm has invested in Pelago Bioscience, entering a partnership with the founders of Pelago to accelerate platform expansion. Founded in 2013, Pelago is a fast-growing…

You must be a HMI Subscriber to view this content.

Subscribe Now »